Secretory phosphoprotein 1 (SPP1), also known as bone bridge protein (OPN), is an integrin-binding glycophosphoprotein and has been shown to be overexpressed in many cancers such as hepatocellular carcinoma, lung cancer, prostate cancer, and breast cancer [40–42]. This evidence concerns the gene SPP1 and prostate cancer.